← FDA Drug Approvals (Drugs@FDA)
AMLODIPINE BESYLATE AND VALSARTAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2015-03-30
Drug application
- FDA Application #
ANDA202829
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- AMLODIPINE BESYLATE AND VALSARTAN
- Generic name
- AMLODIPINE AND VALSARTAN
- Active ingredients
- AMLODIPINE BESYLATE; VALSARTAN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NOVEL LABS INC
- Manufacturer
- Lupin Pharmaceuticals,Inc.
- First approval
- 2015-03-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown